NCBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.824000E-01
Normal-vs-Stage2
7.535000E-01
Normal-vs-Stage3
1.625770E-02
Normal-vs-Stage4
7.750000E-01
Stage1-vs-Stage2
6.838200E-01
Stage1-vs-Stage3
2.402400E-02
Stage1-vs-Stage4
7.618200E-01
Stage2-vs-Stage3
1.971870E-02
Stage2-vs-Stage4
5.030400E-01
Stage3-vs-Stage4
1.117700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.747800E-01
Normal-vs-AfricanAmerican
8.085600E-01
Normal-vs-Asian
5.252600E-01
Caucasian-vs-AfricanAmerican
9.691400E-01
Caucasian-vs-Asian
6.135000E-01
AfricanAmerican-vs-Asian
6.914400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.349800E-01
Normal-vs-Female
6.523000E-01
Male-vs-Female
4.736800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.208000E-01
Normal-vs-Age(41-60Yrs)
8.327000E-01
Normal-vs-Age(61-80Yrs)
5.730200E-01
Normal-vs-Age(81-100Yrs)
6.641600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.207400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.949000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.685400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.736200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.111400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.128600E-01
Normal-vs-Daily Drinker
3.511400E-01
Normal-vs-Weekly Drinker
6.353200E-01
Normal-vs-Occasional Drinker
9.371600E-01
Normal-vs-Social Drinker
7.280800E-01
Non Drinker-vs-Daily Drinker
7.242000E-01
Non Drinker-vs-Weekly Drinker
7.455200E-01
Non Drinker-vs-Occasional Drinker
1.467600E-01
Non Drinker-vs-Social Drinker
6.473800E-02
Daily Drinker-vs-Weekly Drinker
5.211800E-01
Daily Drinker-vs-Occasional Drinker
7.291900E-02
Daily Drinker-vs-Social Drinker
3.635800E-02
Weekly Drinker-vs-Occasional Drinker
3.452600E-01
Weekly Drinker-vs-Social Drinker
1.988020E-01
Occasional Drinker-vs-Social Drinker
5.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.431200E-01
Normal-vs-Grade 2
8.131800E-01
Normal-vs-Grade 3
7.782000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.255400E-01
Grade 1-vs-Grade 3
3.377400E-01
Grade 1-vs-Grade 4
8.431200E-01
Grade 2-vs-Grade 3
4.509200E-01
Grade 2-vs-Grade 4
8.131800E-01
Grade 3-vs-Grade 4
7.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.955600E-01
Normal-vs-NonDiabetic
6.935400E-01
Diabetic-vs-NonDiabetic
7.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.900200E-01
Normal-vs-NoPancreatitis
7.179600E-01
Pancreatitis-vs-NoPancreatitis
8.787600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.387600E-01
Normal-vs-N1
7.300600E-01
N0-vs-N1
6.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.714600E-01
Normal-vs-TP53-NonMutant
9.482800E-01
TP53-Mutant-vs-TP53-NonMutant
9.007600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
